LEADER 01436nam  2200433 a 450 
001 9910703501403321
005 20121105103649.0
035   $a(CKB)4970000000026555
035   $a(OCoLC)815956819
035   $a(EXLCZ)994970000000026555
100   $a20121105d2012      ua             0
101 0 $aeng
135   $aurmn|||||||||
181   $ctxt$2rdacontent
182   $cc$2rdamedia
183   $acr$2rdacarrier
200 10$aEnsuring drug quality in global health programs$b[electronic resource] /$f[David Gootnick, Marcia Crosse]
210  1$aWashington, DC :$cU.S. Govt. Accountability Office,$d[2012]
215   $a1 online resource (27 pages) $ccolor illustrations
300   $aTitle from PDF title screen (viewed Oct. 25, 2012).
300   $a"August 1, 2012."
300   $a"GAO-12-897R."
320   $aIncludes bibliographical references.
517 1 $aGlobal health
606   $aWorld health
606   $aDrugs$xStandards
606   $aDrug factories$xQuality control
615  0$aWorld health.
615  0$aDrugs$xStandards.
615  0$aDrug factories$xQuality control.
700   $aGootnick$b David$01383830
701   $aCrosse$b Marcia$01380679
712 02$aUnited States.$bGovernment Accountability Office.
801  0$bGPO
801  1$bGPO
906   $aDOCUMENT
912   $a9910703501403321
996   $aEnsuring drug quality in global health programs$93543688
997   $aUNINA